What is the typical shelf life of modern veterinary vaccines, and how does it affect procurement planning?

Most conventional livestock vaccines maintain efficacy for 18–24 months under proper 2–8°C storage. Procurement officers should align order volumes with vaccination campaign calendars to minimize wastage, particularly for temperature-sensitive live attenuated products [11]. Read More

How do DIVA-compatible vaccines influence trade policy for livestock exporters?

DIVA vaccines allow serological distinction between vaccinated and infected animals, enabling vaccinated herds to maintain disease-free trade status. Countries using DIVA-compatible FMD vaccines can access premium export markets that impose zero-tolerance infection policies [19]. Read More

What role does contract manufacturing play in the Veterinary/Animal Vaccines Market?

Mid-sized innovators increasingly outsource fill-and-finish operations to reduce capital expenditure and accelerate time-to-market [12]. Read More

How are aquaculture vaccines different from terrestrial livestock products in terms of regulatory requirements?

Aquaculture vaccines face distinct environmental release assessments and species-specific efficacy trials not required for land-animal products. Regulatory timelines tend to be 30–40% longer, which constrains pipeline throughput in this high-growth sub-segment [25]. Read More

What pricing models do governments use for centralized veterinary vaccine procurement?

Most national programs use competitive tender frameworks with 2–3 year supply agreements, negotiating per-dose prices 40–60% below retail rates. Volume guarantees offset lower margins for manufacturers [10]. Read More

How does climate change affect disease distribution and vaccine demand patterns?

Rising temperatures are expanding vector ranges for diseases like Rift Valley fever and bluetongue into previously unaffected temperate zones. This geographic expansion creates new addressable markets for vaccines historically limited to tropical regions [23]. Read More

What is the investment profile for building a greenfield veterinary vaccine manufacturing plant?

A modern facility with BSL-3 containment and multi-species production capability requires USD 150–400 million in capital expenditure and 3–5 years from groundbreaking to regulatory approval, depending on jurisdiction and product complexity [12]. Read More

Veterinary/Animal Vaccines Market (2026 - 2035)

ID: MRFR/Pharma/1994-CR

133 Pages

Vikita Thakur

Last Updated: July 08, 2026

Veterinary Animal Vaccines Market Research Report Information By Type (Livestock Vaccines, Porcine Vaccines), Technology (Live Attenuated Vaccines, Inactivated Vaccines), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2035

Veterinary/Animal Vaccines Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)7.85%

2025 Market SizeUSD 9.65 Billion

2035 Market SizeUSD 20.57 Billion

Key Players

Zoetis Inc.

Merck Animal Health

Boehringer Ingelheim

Elanco Animal Health

Ceva Santé Animale

Virbac

Trends

Antimicrobial Resistance and the Shift to Preventive Immunization
Recurring Panzootic Events and Emergency Procurement
Government Mandates and Centralized Procurement

Opportunities

mRNA and Self-Amplifying RNA Platforms
Digital Vaccination Registries and Data Monetization
Expanding E-Commerce Distribution in Rural Markets

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Antimicrobial Resistance and Preventive Immunization Shift | |
  2. 3.1.2 Recurring HPAI and ASF Panzootic Events | |
  3. 3.1.3 Government Vaccination Mandates and Centralized Procurement | |
  4. 3.1.4 Recombinant and mRNA Platform Maturation | |
  5. 3.1.5 Companion-Animal Premiumization and Pet Insurance Growth | |
  6. 3.1.6 E-Commerce Vaccine Distribution Expansion | |
  7. 3.1.7 Digital Cold-Chain and IoT Monitoring |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 Cold-Chain Infrastructure Gaps in Emerging Economies | |
  2. 3.2.2 Veterinary Workforce Shortages | |
  3. 3.2.3 Fragmented Regulatory Approval Pathways | |
  4. 3.2.4 Vaccine Hesitancy Among Smallholder Farmers | |
  5. 3.2.5 Price Sensitivity in Low-Income Livestock Economies |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 mRNA and Self-Amplifying RNA Platforms | |
  2. 3.3.2 Digital Vaccination Registries and Data Monetization | |
  3. 3.3.3 Expanding E-Commerce Distribution in Rural Markets | |
  4. 3.3.4 Emerging Market Government Procurement Programs | |
  5. 3.3.5 Combination and Multivalent Vaccine Development |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Veterinary/Animal Vaccines Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Animal Type | |
  1. 5.1.1 Livestock Animal Vaccines | |
  2. 5.1.2 Companion Animal Vaccines |
2. 5.2 By Technology | |
  1. 5.2.1 Live Attenuated | |
  2. 5.2.2 Inactivated / Killed | |
  3. 5.2.3 Toxoid | |
  4. 5.2.4 Recombinant / Sub-unit | |
  5. 5.2.5 DNA / mRNA |
3. 5.3 By Disease Indication | |
  1. 5.3.1 Foot-and-Mouth Disease (FMD) | |
  2. 5.3.2 Newcastle Disease | |
  3. 5.3.3 Avian Influenza | |
  4. 5.3.4 Rabies | |
  5. 5.3.5 Porcine Reproductive and Respiratory Syndrome (PRRS) | |
  6. 5.3.6 Other Indications |
4. 5.4 By Route of Administration | |
  1. 5.4.1 Parenteral (Injectable) | |
  2. 5.4.2 Oral | |
  3. 5.4.3 Needle-Free / Intranasal / Spray |
5. 5.5 By Distribution Channel | |
  1. 5.5.1 Veterinary Hospitals & Clinics | |
  2. 5.5.2 Government / Institutional Procurement | |
  3. 5.5.3 Online / E-Commerce
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Zoetis Inc. | |
  2. 7.3.2 Merck Animal Health (MSD) | |
  3. 7.3.3 Boehringer Ingelheim | |
  4. 7.3.4 Elanco Animal Health | |
  5. 7.3.5 Ceva Santé Animale | |
  6. 7.3.6 Virbac | |
  7. 7.3.7 Phibro Animal Health | |
  8. 7.3.8 HIPRA | |
  9. 7.3.9 Hester Biosciences | |
  10. 7.3.10 Indian Immunologicals
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 mRNA and Precision Vaccinology |
2. 8.2 AI-Driven Epidemiological Surveillance |
3. 8.3 Sustainability and Low-Carbon Manufacturing |
4. 8.4 Platform Economics and Subscription-Based Herd Health
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Veterinary/Animal Vaccines Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Veterinary/Animal Vaccines Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Veterinary/Animal Vaccines Market – Driver Impact Analysis |
TABLE 4 Global Veterinary/Animal Vaccines Market – Restraint Impact Analysis |
TABLE 5 Global Veterinary/Animal Vaccines Market Size, by Animal Type, 2021–2035 (USD Billion) |
TABLE 6 Global Veterinary/Animal Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 7 Global Veterinary/Animal Vaccines Market Size, by Disease Indication, 2021–2035 (USD Billion) |
TABLE 8 Global Veterinary/Animal Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 9 Global Veterinary/Animal Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion) |
TABLE 10 Global Veterinary/Animal Vaccines Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 11 North America Veterinary/Animal Vaccines Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 Europe Veterinary/Animal Vaccines Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 Asia-Pacific Veterinary/Animal Vaccines Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 South America Veterinary/Animal Vaccines Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 15 Middle East & Africa Veterinary/Animal Vaccines Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 16 Competitive Benchmarking Matrix – Global Veterinary/Animal Vaccines Market, 2025 |
TABLE 17 Company Profiles – Key Players, Global Veterinary/Animal Vaccines Market |
TABLE 18 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 19 Report Scope and Methodology |
TABLE 20 Detailed Sources and Citations |
TABLE 21 North America Veterinary/Animal Vaccines Market Size, by Animal Type, 2021–2035 (USD Billion) |
TABLE 22 North America Veterinary/Animal Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 23 North America Veterinary/Animal Vaccines Market Size, by Disease Indication, 2021–2035 (USD Billion) |
TABLE 24 North America Veterinary/Animal Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 25 North America Veterinary/Animal Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion) |
TABLE 26 Europe Veterinary/Animal Vaccines Market Size, by Animal Type, 2021–2035 (USD Billion) |
TABLE 27 Europe Veterinary/Animal Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 28 Europe Veterinary/Animal Vaccines Market Size, by Disease Indication, 2021–2035 (USD Billion) |
TABLE 29 Europe Veterinary/Animal Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 30 Europe Veterinary/Animal Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion) |
TABLE 31 Asia-Pacific Veterinary/Animal Vaccines Market Size, by Animal Type, 2021–2035 (USD Billion) |
TABLE 32 Asia-Pacific Veterinary/Animal Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 33 Asia-Pacific Veterinary/Animal Vaccines Market Size, by Disease Indication, 2021–2035 (USD Billion) |
TABLE 34 Asia-Pacific Veterinary/Animal Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 35 Asia-Pacific Veterinary/Animal Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion) |
TABLE 36 South America Veterinary/Animal Vaccines Market Size, by Animal Type, 2021–2035 (USD Billion) |
TABLE 37 South America Veterinary/Animal Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 38 South America Veterinary/Animal Vaccines Market Size, by Disease Indication, 2021–2035 (USD Billion) |
TABLE 39 South America Veterinary/Animal Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 40 South America Veterinary/Animal Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion) |
TABLE 41 Middle East & Africa Veterinary/Animal Vaccines Market Size, by Animal Type, 2021–2035 (USD Billion) |
TABLE 42 Middle East & Africa Veterinary/Animal Vaccines Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 43 Middle East & Africa Veterinary/Animal Vaccines Market Size, by Disease Indication, 2021–2035 (USD Billion) |
TABLE 44 Middle East & Africa Veterinary/Animal Vaccines Market Size, by Route of Administration, 2021–2035 (USD Billion) |
TABLE 45 Middle East & Africa Veterinary/Animal Vaccines Market Size, by Distribution Channel, 2021–2035 (USD Billion)
13 LIST OF FIGURES |
FIGURE 1 Veterinary/Animal Vaccines Market Dynamics – Drivers, Restraints, and Opportunities |
FIGURE 2 Industry Value Chain Analysis |
FIGURE 3 Porter's Five Forces Analysis |
FIGURE 4 Global Veterinary/Animal Vaccines Market Size Trend (USD Billion), 2021–2035 |
FIGURE 5 Veterinary/Animal Vaccines Market Share, by Animal Type, 2025 |
FIGURE 6 Veterinary/Animal Vaccines Market Share, by Technology, 2025 |
FIGURE 7 Veterinary/Animal Vaccines Market Share, by Disease Indication, 2025 |
FIGURE 8 Veterinary/Animal Vaccines Market Share, by Route of Administration, 2025 |
FIGURE 9 Veterinary/Animal Vaccines Market Share, by Distribution Channel, 2025 |
FIGURE 10 Veterinary/Animal Vaccines Market Share, by Region, 2025 |
FIGURE 11 North America Veterinary/Animal Vaccines Market Size (USD Billion), 2021–2035 |
FIGURE 12 Europe Veterinary/Animal Vaccines Market Size (USD Billion), 2021–2035 |
FIGURE 13 Asia-Pacific Veterinary/Animal Vaccines Market Size (USD Billion), 2021–2035 |
FIGURE 14 South America Veterinary/Animal Vaccines Market Size (USD Billion), 2021–2035 |
FIGURE 15 Middle East & Africa Veterinary/Animal Vaccines Market Size (USD Billion), 2021–2035 |
FIGURE 16 Competitive Landscape – Market Share Analysis, 2025 |
FIGURE 17 Competitive Benchmarking Radar Chart – Top 10 Players

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
Animal Type	Livestock Animal Vaccines, Companion Animal Vaccines	Livestock Animal Vaccines	Companion Animal Vaccines
Technology	Live Attenuated, Inactivated / Killed, Toxoid, Recombinant / Sub-unit, DNA / mRNA	Live Attenuated	DNA / mRNA
Disease Indication	FMD, Newcastle Disease, Avian Influenza, Rabies, PRRS, Other	Newcastle Disease	Avian Influenza
Route of Administration	Parenteral, Oral, Needle-Free / Intranasal / Spray	Parenteral	Needle-Free / Intranasal / Spray
Distribution Channel	Veterinary Hospitals & Clinics, Government / Institutional Procurement, Online / E-Commerce	Veterinary Hospitals & Clinics	Online / E-Commerce

Market Segmentation Overview

By Animal Type

Sub-Segment	Key Trend
Livestock Animal Vaccines	Government mandates and export compliance drive non-discretionary procurement volumes
Companion Animal Vaccines	Pet insurance penetration and premiumization fuel above-average growth rates

The animal type dimension reflects the dual demand structure of the Veterinary/Animal Vaccines Market: regulatory-driven livestock programs that provide volume stability, and consumer-driven companion-animal spending that delivers margin expansion and premium pricing power.

By Technology

Sub-Segment	Key Trend
Live Attenuated	Cost-effective mass-administration via drinking water and spray routes
Inactivated / Killed	Preferred safety profile for pregnant and immunocompromised animals
Toxoid	Anchored by clostridial disease prevention in cattle and sheep
Recombinant / Sub-unit	DIVA compatibility and thermostability attract R&D investment
DNA / mRNA	Rapid-design platforms enable sub-100-day responses to novel pathogens

Technology is the most dynamic segmentation dimension, with legacy platforms maintaining volume dominance while next-generation nucleic-acid and recombinant systems capture disproportionate R&D capital and regulatory attention.

By Disease Indication

Sub-Segment	Key Trend
Foot-and-Mouth Disease (FMD)	Mandatory biannual vaccination in major cattle-producing nations
Newcastle Disease	Universal poultry vaccination standard across commercial operations
Avian Influenza	HPAI panzootic preparedness drives emergency and prophylactic demand
Rabies	Public health zoonotic control mandates sustain baseline demand
PRRS	Swine production intensification expands addressable herds
Other Indications	Diverse portfolio spanning canine, feline, equine, and aquaculture pathogens

Disease indication segmentation maps directly to outbreak epidemiology and regulatory response cycles, making it the most event-sensitive dimension of market demand.

By Route of Administration

Sub-Segment	Key Trend
Parenteral (Injectable)	Established efficacy data and universal regulatory acceptance
Oral	Wildlife rabies baiting and select livestock applications
Needle-Free / Intranasal / Spray	Labor cost reduction and scalability for poultry and aquaculture

Administration route segmentation reflects the tension between proven injectable delivery and the operational efficiency gains offered by mass-application needle-free systems.

By Distribution Channel

Sub-Segment	Key Trend
Veterinary Hospitals & Clinics	Professional-administered core vaccines for companion animals
Government / Institutional Procurement	Centralized tenders for national livestock vaccination campaigns
Online / E-Commerce	Disintermediation and rural access expansion via mobile platforms

Distribution channel evolution is reshaping last-mile access, with e-commerce growth compressing traditional clinic-based margins while expanding the total addressable market into previously underserved geographies.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”